Recombinant EIF4E antibody (pSer209)
Quick Overview for Recombinant EIF4E antibody (pSer209) (ABIN7127691)
Target
See all EIF4E AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- pSer209
-
Cross-Reactivity
- Human
-
Purification
- Affinity-chromatography
-
Immunogen
- A synthesized peptide derived from human Phospho-EIF4E (S209)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: WB:1:500-1:5000, IHC:1:50-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- EIF4E (Eukaryotic Translation Initiation Factor 4E (EIF4E))
-
Alternative Name
- EIF4E
-
Background
-
Background: Recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation of protein synthesis and facilitates ribosome binding by inducing the unwinding of the mRNAs secondary structures. Component of the CYFIP1-EIF4E-FMR1 complex which binds to the mRNA cap and mediates translational repression. In the CYFIP1-EIF4E-FMR1 complex this subunit mediates the binding to the mRNA cap.
Aliases: Eukaryotic translation initiation factor 4E, eIF-4E, eIF4E, eIF-4F 25 kDa subunit, mRNA cap-binding protein, EIF4E, EIF4EL1, EIF4F
-
UniProt
- P06730
-
Pathways
- BCR Signaling
Target
-